A detailed history of John G Ullman & Associates Inc transactions in Azenta, Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 80,968 shares of AZTA stock, worth $4.26 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
80,968
Previous 82,118 1.4%
Holding current value
$4.26 Million
Previous $5.35 Million 8.77%
% of portfolio
0.77%
Previous 0.87%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$57.82 - $67.51 $66,493 - $77,636
-1,150 Reduced 1.4%
80,968 $4.88 Million
Q4 2023

Jan 31, 2024

SELL
$44.02 - $66.3 $11,005 - $16,575
-250 Reduced 0.3%
82,118 $5.35 Million
Q3 2023

Nov 01, 2023

BUY
$44.08 - $57.76 $395,573 - $518,338
8,974 Added 12.23%
82,368 $4.13 Million
Q2 2023

Aug 21, 2023

BUY
$36.45 - $46.68 $1.17 Million - $1.49 Million
31,981 Added 77.22%
73,394 $3.43 Million
Q1 2023

May 05, 2023

BUY
$39.51 - $61.95 $49,387 - $77,437
1,250 Added 3.11%
41,413 $1.85 Million
Q4 2022

Feb 08, 2023

SELL
$38.6 - $62.07 $61,760 - $99,312
-1,600 Reduced 3.83%
40,163 $2.34 Million
Q3 2022

Oct 19, 2022

SELL
$42.86 - $77.02 $4,286 - $7,702
-100 Reduced 0.24%
41,763 $1.79 Million
Q1 2022

Apr 29, 2022

SELL
$76.3 - $103.81 $17,472 - $23,772
-229 Reduced 0.54%
41,863 $3.47 Million
Q4 2021

Jan 26, 2022

SELL
$92.98 - $124.15 $4,741 - $6,331
-51 Reduced 0.12%
42,092 $4.34 Million
Q3 2021

Nov 02, 2021

SELL
$77.49 - $109.17 $23,247 - $32,751
-300 Reduced 0.71%
42,143 $4.31 Million
Q2 2021

Jul 23, 2021

SELL
$86.59 - $107.47 $25,977 - $32,241
-300 Reduced 0.7%
42,443 $4.04 Million
Q1 2021

Apr 22, 2021

SELL
$66.32 - $90.93 $754,389 - $1.03 Million
-11,375 Reduced 21.02%
42,743 $3.49 Million
Q4 2020

Feb 05, 2021

SELL
$46.7 - $75.22 $775,220 - $1.25 Million
-16,600 Reduced 23.47%
54,118 $3.67 Million
Q3 2020

Nov 06, 2020

SELL
$42.77 - $56.69 $937,518 - $1.24 Million
-21,920 Reduced 23.66%
70,718 $3.27 Million
Q2 2020

Jul 29, 2020

SELL
$26.54 - $44.24 $11,943 - $19,908
-450 Reduced 0.48%
92,638 $4.1 Million
Q1 2020

Apr 14, 2020

SELL
$22.69 - $44.14 $18,152 - $35,312
-800 Reduced 0.85%
93,088 $2.84 Million
Q4 2019

Jan 29, 2020

SELL
$35.49 - $48.05 $1.43 Million - $1.94 Million
-40,300 Reduced 30.03%
93,888 $3.94 Million
Q3 2019

Oct 21, 2019

SELL
$30.18 - $41.75 $276,358 - $382,304
-9,157 Reduced 6.39%
134,188 $4.97 Million
Q2 2019

Aug 02, 2019

SELL
$29.53 - $41.1 $79,731 - $110,970
-2,700 Reduced 1.85%
143,345 $5.56 Million
Q1 2019

Apr 30, 2019

SELL
$24.38 - $33.75 $21,332 - $29,531
-875 Reduced 0.6%
146,045 $4.28 Million
Q4 2018

Jan 29, 2019

SELL
$23.22 - $35.29 $32,856 - $49,935
-1,415 Reduced 0.95%
146,920 $3.85 Million
Q3 2018

Nov 02, 2018

SELL
$28.71 - $39.6 $2.2 Million - $3.04 Million
-76,801 Reduced 34.11%
148,335 $5.2 Million
Q2 2018

Jul 23, 2018

SELL
$24.88 - $36.36 $44,609 - $65,193
-1,793 Reduced 0.79%
225,136 $7.34 Million
Q1 2018

Apr 19, 2018

SELL
$23.3 - $30.15 $33,295 - $43,084
-1,429 Reduced 0.63%
226,929 $6.15 Million
Q4 2017

Jan 31, 2018

SELL
$22.54 - $34.39 $796,541 - $1.22 Million
-35,339 Reduced 13.4%
228,358 $5.45 Million
Q3 2017

Nov 03, 2017

BUY
$22.6 - $30.36 $5.96 Million - $8.01 Million
263,697
263,697 $8.01 Million

Others Institutions Holding AZTA

About Azenta, Inc.


  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.95B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.